PR Newswire (Thu, 8:15AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (May 3, 2013)
-
-
PR Newswire (Apr 18, 2013)
-
NW Bio's Phase III Trial With DCVax®-L For Brain Cancer "Adopted" As A National Priority Trial In UKPR Newswire (Apr 16, 2013)
-
-
PR Newswire (Apr 8, 2013)
-
-
-
-
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
-
PR Newswire (Mar 12, 2013)
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
Northwest Biotherapeutics Raises $12M And Uplists To NasdaqRichard Richter • Mon, Dec 24, 2012
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biotechnology In 2012: The Best Performing IndustryRyan's View • Tue, Dec 4, 2012
-
-
-
-
-
-
-
-
-
-
There are no Transcripts on NWBO.
-
PR Newswire (May 3, 2013)
-
PR Newswire (Apr 18, 2013)
-
NW Bio's Phase III Trial With DCVax®-L For Brain Cancer "Adopted" As A National Priority Trial In UKPR Newswire (Apr 16, 2013)
-
PR Newswire (Apr 8, 2013)
-
PR Newswire (Mar 19, 2013)
-
PR Newswire (Mar 18, 2013)
-
PR Newswire (Mar 12, 2013)
-
PR Newswire (Feb 15, 2013)
-
PR Newswire (Feb 11, 2013)
-
PR Newswire (Jan 29, 2013)
NWBO vs. ETF Alternatives
Company Description
Northwest Biotherapeutics is a development stage biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the United States... More
